Diuretic treatment of heart failure

Research output: Contribution to journalArticle

Abstract

Heart failure is a state of avid renal salt and water retention. These responses initially help to restore cardiac output, but eventually become maladaptive when cardiac output is not augmented by volume expansion and when edema formation develops. In the kidney, this antinatriuretic/antidiuretic milieu is established by neurohumoral activation, namely, the sympathetic nerves, renin-angiotensin-aldosterone axis, and vasopressin. Diuretics, particularly loop diuretics, are important therapeutic tools in the management of heart failure; however, altered drug pharmacokinetics and pharmacodynamics may result in reduced efficacy. Management strategies that have been shown to be effective in overcoming diuretic resistance in heart failure are (1) sodium restriction, (2) increased dosing frequency, (3) intravenous route of administration, (4) high-dose loop diuretic administration, (5) continuous intravenous infusion of loop diuretics, and (6) combination of loop diuretics with distal-acting diuretics. In addition to their natriuretic effect, loop diuretics possess immediate and direct cardiovascular actions which are particularly important in the setting of decompensated heart failure.

Original languageEnglish (US)
Pages (from-to)181-191
Number of pages11
JournalHeart Failure
Volume10
Issue number5
StatePublished - 1994

Fingerprint

Sodium Potassium Chloride Symporter Inhibitors
Treatment Failure
Diuretics
Heart Failure
Cardiac Output
Natriuretic Agents
Kidney
Angiotensins
Aldosterone
Vasopressins
Renin
Intravenous Infusions
Intravenous Administration
Edema
Pharmacokinetics
Salts
Sodium
Water
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Diuretic treatment of heart failure. / Mokrzycki, Michele H.

In: Heart Failure, Vol. 10, No. 5, 1994, p. 181-191.

Research output: Contribution to journalArticle

Mokrzycki, MH 1994, 'Diuretic treatment of heart failure', Heart Failure, vol. 10, no. 5, pp. 181-191.
Mokrzycki, Michele H. / Diuretic treatment of heart failure. In: Heart Failure. 1994 ; Vol. 10, No. 5. pp. 181-191.
@article{5a429d2aad0540fd83672f297563bd95,
title = "Diuretic treatment of heart failure",
abstract = "Heart failure is a state of avid renal salt and water retention. These responses initially help to restore cardiac output, but eventually become maladaptive when cardiac output is not augmented by volume expansion and when edema formation develops. In the kidney, this antinatriuretic/antidiuretic milieu is established by neurohumoral activation, namely, the sympathetic nerves, renin-angiotensin-aldosterone axis, and vasopressin. Diuretics, particularly loop diuretics, are important therapeutic tools in the management of heart failure; however, altered drug pharmacokinetics and pharmacodynamics may result in reduced efficacy. Management strategies that have been shown to be effective in overcoming diuretic resistance in heart failure are (1) sodium restriction, (2) increased dosing frequency, (3) intravenous route of administration, (4) high-dose loop diuretic administration, (5) continuous intravenous infusion of loop diuretics, and (6) combination of loop diuretics with distal-acting diuretics. In addition to their natriuretic effect, loop diuretics possess immediate and direct cardiovascular actions which are particularly important in the setting of decompensated heart failure.",
author = "Mokrzycki, {Michele H.}",
year = "1994",
language = "English (US)",
volume = "10",
pages = "181--191",
journal = "Heart Failure",
issn = "8755-7673",
publisher = "Le Jacq Communications, Inc.",
number = "5",

}

TY - JOUR

T1 - Diuretic treatment of heart failure

AU - Mokrzycki, Michele H.

PY - 1994

Y1 - 1994

N2 - Heart failure is a state of avid renal salt and water retention. These responses initially help to restore cardiac output, but eventually become maladaptive when cardiac output is not augmented by volume expansion and when edema formation develops. In the kidney, this antinatriuretic/antidiuretic milieu is established by neurohumoral activation, namely, the sympathetic nerves, renin-angiotensin-aldosterone axis, and vasopressin. Diuretics, particularly loop diuretics, are important therapeutic tools in the management of heart failure; however, altered drug pharmacokinetics and pharmacodynamics may result in reduced efficacy. Management strategies that have been shown to be effective in overcoming diuretic resistance in heart failure are (1) sodium restriction, (2) increased dosing frequency, (3) intravenous route of administration, (4) high-dose loop diuretic administration, (5) continuous intravenous infusion of loop diuretics, and (6) combination of loop diuretics with distal-acting diuretics. In addition to their natriuretic effect, loop diuretics possess immediate and direct cardiovascular actions which are particularly important in the setting of decompensated heart failure.

AB - Heart failure is a state of avid renal salt and water retention. These responses initially help to restore cardiac output, but eventually become maladaptive when cardiac output is not augmented by volume expansion and when edema formation develops. In the kidney, this antinatriuretic/antidiuretic milieu is established by neurohumoral activation, namely, the sympathetic nerves, renin-angiotensin-aldosterone axis, and vasopressin. Diuretics, particularly loop diuretics, are important therapeutic tools in the management of heart failure; however, altered drug pharmacokinetics and pharmacodynamics may result in reduced efficacy. Management strategies that have been shown to be effective in overcoming diuretic resistance in heart failure are (1) sodium restriction, (2) increased dosing frequency, (3) intravenous route of administration, (4) high-dose loop diuretic administration, (5) continuous intravenous infusion of loop diuretics, and (6) combination of loop diuretics with distal-acting diuretics. In addition to their natriuretic effect, loop diuretics possess immediate and direct cardiovascular actions which are particularly important in the setting of decompensated heart failure.

UR - http://www.scopus.com/inward/record.url?scp=0028130177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028130177&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028130177

VL - 10

SP - 181

EP - 191

JO - Heart Failure

JF - Heart Failure

SN - 8755-7673

IS - 5

ER -